baber/WOPTO huggingface dataset:
Patent FI-960171-A0 (FI)
Inventor: NEGRERIE MARCEL
IPC: C23C18/28
Filed: 1996-01-15
Abstract: PCT No. PCT/FR94/00860 Sec. 371 Date Apr. 12, 1996 Sec. 102(e) Date Apr. 12, 1996 PCT Filed Jul. 11, 1994 PCT Pub. No. WO95/02715 PCT Pub. Date Jan. 26, 1995A method comprising the steps of (a) preparing a divided copper oxide dispersion (4) including a solvent and a selected binder, (b) applying said dispersion to a non-conductive substrate (1) to form a film (5), (c) forming a Cu film (9) with a suitable reagent, and (d) electrolytically depositing at least one metal film (11) on said film (9).
Patent FI-961925-A0 (FI)
Inventor: NILSSON VALTER
IPC: B23K9/12
Filed: 1996-05-07
Abstract: PCT No. PCT/SE94/01007 Sec. 371 Date Apr. 25, 1996 Sec. 102(e) Date Apr. 25, 1996 PCT Filed Oct. 26, 1994 PCT Pub. No. WO95/13162 PCT Pub. Date May 18, 1995The present invention relates to a device for automatically cleaning and curing off the wire in the nozzles of MIG/MAG welding equipment. It is characterized in that the device, which is portable, comprises a centering member (2) for insertion of a nozzle (1), and milling means (4, 5) to millcoated parts (6) of the nozzle, as well as possibly a cutting member (10) for the foremost part of the welding bead (7) of material applied, the milling means and cutting member if any (4, 5 and 10, respectively) being rotated by a drive means (3), designed to start automatically upon insertion of the nozzle (1).
Patent FI-963970-A0 (FI)
Inventor: DUCHACZEK HUBERT
IPC: B01D53/70
Filed: 1996-10-03
Abstract: The invention concerns a process for purifying waste furnace gases and for using the resultant filter residue. Alkaline aggregates, containing sodium or potassium as the cation, are added to the waste furnace gas. In a subsequent stage, dusts and droplets are filtered out of the waste furnace gas. The resultant filter residue is added to the cover salt (7) necessary when melting secondary aluminium.
Patent FI-964577-A0 (FI)
Inventor: SJOEBERG MATHILDA
IPC: C07H21/04
Filed: 1996-11-15
Abstract: The present invention is directed to alphavirus expression vectors comprising at least part of an alphavirus genome and heterologous RNA inserted downstream of an alphavirus base sequence having translation enhancing activity. Such vectors can be used to achieve enhanced levels of expression of DNA or cDNA coding for a desired product and being complementary to said heterologous RNA after introduction of said vector in eukaryotic cells in cell culture or in a living body. The expression product may have therapeutic or prophylactic activity.
Patent FI-970190-A0 (FI)
Inventor: LOEVGREN STEN
IPC: B65G63/02
Filed: 1997-01-17
Abstract: PCT No. PCT/SE95/00869 Sec. 371 Date Jan. 15, 1997 Sec. 102(e) Date Jan. 15, 1997 PCT Filed Jul. 18, 1995 PCT Pub. No. WO96/02445 PCT Pub. Date Feb. 1, 1996The invention is related to a method for transferring load units between two carriers. A first carrier includes a transfer arrangement which is an extendable and retractable arm that moves transverse to the first carrier and forms a path for a carrying member movable along the arm. A second carrier includes elevating securing members which engage a load unit. The method includes the steps of extending the arm from the first carrier so that the arm will be supported by the second carrier, displacing the carrying member along the arm to a position under the load on the second carrier, lowering the load onto the carrying member by lowering the securing members, and transferring the load with the carrying member along the arm to the first carrier.
Patent FI-973737-A0 (FI)
Inventor: TARNANEN TEEMU
IPC: H04W8/18
Filed: 1997-09-19
Abstract: A digital mobile communication system is provided with a facility by means of which it can establish a connection to the Internet network via an Internet access point "(IAP"). IAP settings needed for establishing a connection are stored in a mobile station. When a mobile station roams, the closest point may, however, change, and IAP settings should be updated in the mobile station. The invention comprises dividing the mobile communication system into IAP areas, which are given preferred IAPs. For example, an IAP area may be a mobile communication network. Mobile communication networks broadcast system information on the basis of which a mobile station may detect that the LAP area has changed and start a procedure for updating IAP settings. Updating may comprise retrieval of IAP settings from a special server in the network maintained by an Internet service provider. For example, retrieval can be done via a short message service center. In one embodiment, the mobile communication network broadcasts messages giving recommended IAP settings to mobile stations.
Patent FI-981808-A0 (FI)
Inventor: DE VOS ROLF
IPC: D21C9/153
Filed: 1998-08-24
Abstract: A method for bleaching medium consistency pulp with an ozone-containing gas is disclosed. The highly concentrated ozone-carrying stream is introduced into the pulp stream without mechanical mixing, or accompanied by mixing of moderate intensity. Thus, advance is taken by the rapid reaction of ozone in plug-flow conditions without the use of fiber-destroying shear forces.
Patent IL-69683-A0 (IL)
Title: Isoquinoline derivatives,a process for their preparation,pharmaceutical formulations based on these compounds and the use thereof
IPC: C07D401/12
Filed: 1983-09-07
Abstract: Isoquinoline-4-carboxylic acid derivatives of the formula I <IMAGE>  I  in which m, n, R1, R2, R3, A and X have the meansings indicated, and physiologically acceptable acid addition salts thereof, a process for their preparation, pharmaceutical formulations based on these compounds and the use thereof as antiarrythmic agents.
Patent IL-72208-A0 (IL)
Title: Aryl and heteroaryl(7-(aryl and heteroaryl)pyrazolo-(1,5-a)pyrimidin-3-yl)-methanones
IPC: A61P25/20
Filed: 1984-06-22
Abstract: Aryl and heteroaryl [7-(aryl and heteroaryl)-pyrazolo[1,5-a[pyrimidin-3-yl]methanones which are new compounds active as anxiolytic, anticonvulsant, sedative-hypnotic and skeletal muscle relaxant agents in mammals and the novel process of making these compounds.
Patent IL-73323-A0 (IL)
Title: Organosilicon compounds and the use thereof
IPC: C09K3/00
Filed: 1984-10-26
Abstract: Organosilicon compounds which are silanes or siloxanes characterised by the presence of silicon-bonded groups of the formula <CHEM> in which X represents -OH, -OCH3 or OC2H5 when p = 1 or -OH or dialkylamino when p = 0, n can be 0 or 1 and p = 0 or 1. The compounds are prepared by the reaction of a silane or siloxane containing silicon-bonded hydrogen with a compound <CHEM> e
Patent IL-74330-A0 (IL)
Title: Repair plug assembly for and method of repairing of vessel having a corrosion resistant lining
IPC: F16B43/00
Filed: 1985-02-13
Abstract: A repair plug assembly for repairing a defect such as a hole in the lined surface of a corrosion resistant glass or vftreous lined metal vessel and which assembly includes a stud affixed in the hole of the vessel and having an exposed unthreaded surface at the lined surface over which is packed a flexible and compactible sealing material which is contained in sealing position over the hole opening by means of a containing ring and overlying dome-shaped cap member.
Patent IL-78866-A0 (IL)
Title: Certain phosphonic acids and derivatives
IPC: A61P25/08
Filed: 1986-05-21
Abstract: The present invention is concerned with the compounds of formula I,   <CHEM> wherein one or both of the acidic hydroxy groups of the phosphonic acid moiety may be etherified, m reprensents one or zero, R<1> is carboxy, esterified carboxy or amidated carboxy, wherein the five or six-membered heterocyclic ring may be additionally substituted on carbon and/or nitrogen, may have present a carbon-carbon double bond or may be fused on adjacent carbon atoms with a six-membered carbocyclic ring, A represents a direct bond or lower alkylene provided that A does not represent a direct bond when the heterocyclic ring together with substituent R<1> represents 2-carboxypyrrolidinyl; and salts thereof. These compounds are useful for the treatment of nervous system disorders in mammals and as antagonists of the N-methyl-D-aspartate sensitive excitatory amino acid receptor.
Patent IL-86865-A0 (IL)
Title: Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
IPC: A61P35/00
Filed: 1988-06-26
Abstract: A diagnostic method for assessing defects in RNase L comprising measuring activated RNase L in a cytoplasmic extract of a patient's mononuclear cells, preferably by measuring the mononuclear cells' ability to generate specific cleavage products when incubated with 28S and 18S RNA or the mononuclear cells' ability to generate cleavage products over a predetermined period of time.
Patent IL-93941-A0 (IL)
Title: Retinoblastoma gene product antibodies and their use in cancer prognosis
IPC: G01N33/577
Filed: 1990-03-29
Abstract: The present invention discloses a method of determining the prognosis of a cancer patient by determining the presence or absence of Retinoblastoma gene product in tumor antibodies which specifically bind to the hydrophilic c-terminus of the retinoblastoma protein are also provided.
Patent AU-PR567401-A0 (AU)
Title: Circovirus vaccines
IPC: A61P31/20
Filed: 2001-06-14
Abstract: An isolated attenuated circovirus having a mutation in viral nucleic acid encoding viral protein 2 (VP2). The attenuated circovirus is particularly suitable for use in conferring immunity in an animal, particularly birds.
Patent FI-20020073-A0 (FI)
Inventor: NISSINEN VILHO
IPC: B05B13/02
Filed: 2002-01-15
Abstract: A nozzle array for use in the coating of a mobile web-like material has a plurality of high-pressure nozzles ( 2.1, 2.2 ) in the transverse direction of the web. The nozzles ( 2.1, 2.2 ) have been classified by a variable acting on the flow so that the deviation of the variable within the array is smaller than a pre-set value. The yield of each nozzle being the same with optimal precision, an optimally even coating is achieved on the web.
Patent FI-20022082-A0 (FI)
Inventor: VAITTINEN HENRI
IPC: B05C1/08
Filed: 2002-11-22
Abstract: The invention relates to a processing device for processing a coated or uncoated fibrous web, comprising a belt (2) adapted to extend around a guiding element (3), at least one roll (5) being disposed outside said belt to provide a contact area with the belt, such that the belt (2) and the roll (5) establish therebetween a web processing zone for passing a web to be processed therethrough, wherein 
outside the belt (2) is provided a deflection-compensated nip roll (26) to establish a profiling nip with the roll (5), a web (W) being adapted to travel through said profiling nip, that the processing zone length is defined by means of the disposition/adjustment of the belt's (2) guiding element (3) and/or by means of the dimensioning of the roll (5), and that a contact pressure applied to the web in the processing zone is adapted to be adjustable within the range of about 0.01 MPa to about 200 MPa, and that 
the roll (5) comprises a thermal roll, that the belt (2) comprises a metal belt, and that the operating temperature of the thermal roll (5) and/or the metal belt lies within the range of about 50°C to about 400°C, and 
the belt having a thickness of about 0,1 to 3 mm.
Patent IL-102377-A0 (IL)
Title: Preparation of silicon nitride
IPC: C01B21/068
Filed: 1992-07-01
Abstract: The invention relates to a process for the preparation of silicon nitride. According to this process, a primary mixture of silicon and carbon is taken and incorporated in a matrix or a porous layer based on carbon before the carbonitridation reaction. This process makes it possible to obtain Si3N4 in the form of particles of regular and controlled shape, free of whiskers.
Patent IL-105112-A0 (IL)
Title: Semi-synthetic glycosaminoglycans with heparin or heparan structure of alpha-l iduronic-2-o-sulfate acid modified in position 2
IPC: C08B37/10
Filed: 1993-03-19
Abstract: The synthesis of new semi-synthetic glycosaminoglycans with heparin or heparan structure of  alpha -L-iduronic-2-O-sulfate acid modified in position 2 is described in which the sulfate group is, entirely or in part, substituted with a nucleophilic radical. These new semi-synthetic glycosaminoglycans of general formula IV <CHEM> have good pharmaceutical properties in that they may also be absorbed orally and have good anti-thrombotic activity accompanied by low risk of haemorrhage and reduced anti-coagulating activity.
Patent IL-113473-A0 (IL)
Title: Polyenic compounds pharmaceutical and cosmetic compositions containing them and use
IPC: A61K31/32
Filed: 1995-04-24
Abstract: Polyenic cpds. of formula (I) and their salts and optical and geometric isomers, are new. R1 = -CH3, -CH2-O-R9, -CH2-O-CO-R10 or -CO-R11; R2, R3, R5 = H or lower alkyl; R4 = H; R6 = H, 1-20C alkyl, -O-CH2-O-CH2-CH2-O-CH3 or -O-R13; or R4+R6 together with the adjacent benzene ring form a naphthalene ring; R7, R8 = (i) H, (ii) 1-20C alkyl, (iii) cycloaliphatic gp., (iv) -O-CH2-O-CH2-CH2-O-CH3, (v) -O-R13 or (vi) -S(O)nR13; provided that R7 and R8 are not (i), (iv), (v) or (vi) at the same time; R9 = H or lower alkyl; R10 = lower alkyl; R11 = (a) H, (b) lower alkyl, (c) -N(R')R" or (d) -OR12; R', R" = H, lower alkyl, mono- or poly-hydroxyalkyl, aryl (opt. substd.) or an amino acid, peptide or sugar residue or together form a heterocyclic gp.; R12 = H, 1-20C alkyl, alkenyl, mono- or poly-hydroxyalkyl or opt. substd. aryl or aralkyl, or a sugar, aminoacid or peptide residue; R13 = H or 1-20C alkyl; n = 0, 1 or 2.
Patent IL-114924-A0 (IL)
Title: Multi-land multi-mode communication system
IPC: H04B1/69
Filed: 1995-08-14
Abstract: A technique for spread-spectrum communication (figs. 1, 3, 12 and 14) which uses more than one mode and more than one frequency band. Selectable modes include a narrowband mode (113) and spread-spectrum mode (111), or cellular mode and microcellular mode. Selectable frequency bands include both licensed and unlicensed frequency bands, particularly frequency bands including the 902-928 MHz, 1850-1990 MHz and 2.4-2.4835 GHz frequency bands. Spread-spectrum communication channels are 10 MHz or less in width. The frequency band onto which spread-spectrum signals are encoded may be changed upon a change in environment or other control trigger, such as establishment or de-establishment of a communication with a private access network. A multi-band transmitter (fig. 12) comprises a single frequency synthesiser and a frequency source (606) (e.g. a local oscillator), coupled to selectable band pass filter (619, 620). A multi-band receiver (fig 14.) capable of monitoring one or more frequency bands comprises bank of bandpass filters (714, 715) and a demodulator comprising a single frequency synthesiser and a frequency source (721). <IMAGE>
Patent IL-119256-A0 (IL)
Title: 2-cyano-3- mercaptocrotonamides
IPC: C07D295/185
Filed: 1996-09-17
Abstract: Cyano-mercapto-alkenoamide cpds. of formula R1C(SH)=C(CN)CON(R2)(R3) (I) and their stereoisomers and salts are new. R1 = H, 1-17C alkyl, 1-4C haloalkyl; phenyl (opt. substd. by 1 or more halo, NO2, CN, 1-4C alkyl, 1-4C haloalkyl, 1-4C alkoxy, 1-4C haloalkoxy, or phenyl(1-2C)alkyl, benzyl, 3-7C cycloalkyl, 2-3C alkenyl or 2-3C alkynyl; R2 = H, 1-4C alkyl, phenyl, phenyl(1-2C)alkyl or 2-3C alkenyl; R3 = mono, bi or tricyclic unsatd. 3-13C heterocycle contg. 1-4 heteroatoms (O, S, N) having 0-1 of the heteroatoms O or S (opt. substd. by 1 or more of halo, 1-4C alkyl, 1-4C haloalkyl, 1-4C alkoxy, 1-4C haloalkoxy, NO2, OH, COOH, CONH2 or O), phenyl (opt. mono, di or tri-substd., by 1-4C alkyl, 1-4C haloalkyl, 1-4C alkoxy, 1-4C haloalkoxy, 1-4C alkylthio, 1-4C haloalkylthio, halo, NO2, CN, OH, COOH, 1-4C alkylsulphonyl, carbalkoxy (with 1-3C in alkyl), benzoyl (opt. substd. by halo, 1-4C alkyl or 1-4C alkoxy), phenyl (opt. substd. by halo, 1-4C alkyl or 1-4C alkoxy, phenoxy (opt. substd. by 1-3C alkoxy, opt. substd. by halo, 1-3C haloalkoxy or halo(sic)), naphthyl, methylenedioxyphenyl, or (CH2)nCOOR10; or NR2R3 = 4-7 membered ring, opt. substd. by carbonyl on the C next to the N, or a gp. of formula (a); n = 1-12; R10 = H or 1-4C alkyl; W = CH2, CH2CH2, CH2CHMe, CH2CHEt, CH2CHOH, CH2O or CH2S; halo = F, Cl, Br or I; and provided that when R2 and R3 = H, then R1 is not Me, Et or Ph.
Patent IL-124840-A0 (IL)
Title: Process for the preparation of (1s,2r)-1-amino-2- indanol-(r,r)-tartrate methanol solvate
IPC: C07C213/06
Filed: 1998-06-10
Abstract: Process for the preparation of (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate, in which in a solvent a mixture of enantiomers of cis-1-amino-2-indanol reacts at an elevated temperature with (R,R)-tartaric acid and methanol and in which optically enriched (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate crystallizes out, after which the crystals are recovered, the recovery taking place at a temperature between 10 and 50 DEG C in the presence of 0-20 wt.% water relative to the amount of methanol plus solvent, on the understanding that if the reaction mixture is essentially free from water the recovery substantially takes place at a temperature between 30 and 50 DEG C. Preferably the reactants are at least in part contacted with each other at an elevated temperature and only methanol is used as solvent. Preferably the amount of (1S,2R)-1-amino-2-indanol applied is between 0.02 and 0.1 g per ml of solvent. The invention also relates to (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate crystals having a particle size larger than 95  mu m, expressed as DÄv, 0.9Ü, in particular those in which the enantiomeric excess of (1S,2R)-1-amino-2-indanol-(R,R)-tartrate relative to (1R,2S)-1-amino-2-indanol-(R,R)-tartrate is higher than 96%, as well as to application of (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate in the preparation of AIDS inhibitors, in particular indinavir sulphate.
Patent IL-133609-A0 (IL)
Title: A method for high information resolution
IPC: G01N33/531
Filed: 1998-06-19
Abstract: Analytes in a sample are resolved by retentate chromatography in a procedure involving adsorbing the analytes on a substrate under a plurality of different selectivity conditions, and detecting the analytes retained on the substrate by desorption spectrometry. The methods are useful in biology and medicine, including clinical diagnostics and drug discovery.
Patent IL-148195-A0 (IL)
Title: Methods for producing agglomerate and tablets
IPC: A61K47/26
Filed: 2000-09-09
Abstract: The present invention relates to an improved method of producing agglomerates and compressed products containing isomaltulose and/or hydrogenated isomaltulose.
Patent IL-154009-A0 (IL)
Title: Codon-optimized papilloma virus sequences
IPC: A61K48/00
Filed: 2001-07-20
Abstract: The present invention relates to methods and compositions useful in the treatment and prevention of human papilloma virus infections and the symptoms and diseases associated therewith. More particularly, the invention relates to polynucleotide sequences which encode human papilloma virus (HPV) amino acid amino acid sequences, wherein the codon usage pattern of the polynucleotide sequences resemble those of highly expressed mammalian genes.
Patent IL-155608-A0 (IL)
Title: Human cord blood derived unrestricted somatic stem cells (ussc)
IPC: A61K35/545
Filed: 2001-11-03
Abstract: A composition in human cord and placental blood which comprises unrestricted somatic stem cells is described here which can be amplified in vitro to large quantities sufficient for medical applications as regenerative medicines. Initiation and maintenance as well as ex vivo expansion protocols of such stem cells from cord blood is described. Furthermore, it is shown that from these cells employing varying differentiation induction protocols distinct lineage progenitors for hematopoiesis and endothelial, as well as mesenchymal progenitors for muscle bone, cartilage and fat as well as neural progenitors can be cultured and expanded for use in regenerative medicine.
Patent IL-157080-A0 (IL)
Title: Method for detecting cytosine methylation patterns having high sensitivity
IPC: G01N27/447
Filed: 2002-03-08
Abstract: Detecting cytosine methylation in DNA samples by: (i) chemically treating a genomic sample to convert all non-methylated cytosines to uracil while leaving methylated cytosines unchanged; (ii) amplification with 2 primer oligonucleotides and a polymerase; and (iii) analysis of the amplicon and deducing the methylation status of test DNA. Detecting cytosine methylation in DNA samples by: (i) chemically treating a genomic sample to convert all non-methylated cytosines to uracil while leaving methylated cytosines unchanged; (ii) amplification with 2 primer oligonucleotides and a polymerase; and (iii) analysis of the amplicon and deducing the methylation status of test DNA from the presence of an amplicon and/or analysis of additional positions. The sample contains both test DNA and background DNA and step (ii) is designed for preferential amplification of test DNA. An independent claim is also included for a kit containing a bisulfite reagent, primers, additional oligonucleotides that lack a 3'-hydroxy for preparation of an amplicon, and optionally instructions for performing an assay.
Patent IL-159788-A0 (IL)
Title: Method and system for measurement of the duration an area is included in an image stream
IPC: G06T7/60
Filed: 2001-08-16
Abstract: A system and method for calculation of the duration a target area included within an image stream utilizes a three-dimensional model of at least one target area within a site. A counter is incremented during periods, for example on a frame-by-frame basis, when the target area is included in the image stream.
Patent IL-159880-A0 (IL)
Title: Arylsulfonyl derivatives with 5-ht6 receptor affinity
IPC: A61P25/14
Filed: 2002-08-05
Abstract: This invention relates to compounds which have generally 5-HT6 receptor affinity and which are represented by Formula (I):wherein Ar, R<1>, R<2>, R<3 >or R<4 >are as defined in the specification, or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their use as therapeutic agents, and methods of preparation thereof.
Patent IL-183756-A0 (IL)
Title: Security device having a cable
Filed: 2007-06-07
Abstract: Systems and apparatus for a security device for an article having a constrained elongate member are disclosed.
Patent IL-186775-A0 (IL)
Title: Tgf beta 1 specific antibodies
Filed: 2007-10-18
Abstract: TGF-beta 1 binding compositions and reagents related thereto are provided. Methods of using such compositions for therapeutic purpose are also provided.
Patent IL-221699-A0 (IL)
Title: Cotyle comprising a sterile interface
Filed: 2012-08-30
Abstract: The cup has an insertion cup (1) with a hemisphere convex retainer exterior face (2) and concave receiving face (3). The acetabular cup is conditioned and assembled at an infertile state with a fixed articular insertion (4) defined by ceramic engaged in the insertion cup. The insertion cup has a receiving peripheral structure (8) to receive a fixation unit, where the fixation unit fixes a nails impactor (15) of the acetabular cup. The impactor is fixed at the acetabular cup, and structure is fixed with an orientation and implementation insertion (11) that is made of polyethylene.